CD45-PET is a robust, non-invasive tool for imaging inflammation
- PMID: 39843738
- DOI: 10.1038/s41586-024-08441-6
CD45-PET is a robust, non-invasive tool for imaging inflammation
Abstract
Imaging inflammation holds immense potential for advancing the diagnosis, treatment and prognosis of many conditions1-3. The lack of a specific and sensitive positron emission tomography (PET) probe to detect inflammation is a critical challenge. To bridge this gap, we present CD45-PET imaging, which detects inflammation with exceptional sensitivity and clarity in several preclinical models. Notably, the intensity of the CD45-PET signal correlates robustly with the severity of disease in models of inflammatory lung and bowel diseases, outperforming 18F-fluorodeoxyglucose PET, the most widely used imaging modality for inflammation globally. Longitudinal CD45-PET imaging further enables precise monitoring of dynamic changes in tissue-specific inflammatory profiles. Finally, we developed a human CD45-PET probe for clinical translation that effectively detects human immune cells in a humanized mouse model. CD45-PET imaging holds substantial clinical promise, offering a tool for guiding diagnostic and therapeutic decisions for inflammatory diseases through a precise, whole-body assessment of the inflammation profiles of individual patients.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: A.S.F., J.E.R. and M.R. are inventors on a related patent application (PCT/US2024/020183) concerning the design and use of CD45-PET probes for detecting inflammation in inflammatory diseases. The other authors declare no competing interests.
References
-
- Slavich, G. M. Understanding inflammation, its regulation, and relevance for health: a top scientific and public priority. Brain Behav. Immun. 45, 13–14 (2015).
-
- Bennett, J. M., Reeves, G., Billman, G. E. & Sturmberg, J. P. Inflammation—nature’s way to efficiently respond to all types of challenges: implications for understanding and managing “the epidemic” of chronic diseases. Front. Med. 5, 316 (2018).
-
- Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).
-
- Roth, G. A. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018).
-
- Wu, C., Li, F., Niu, G. & Chen, X. PET imaging of inflammation biomarkers. Theranostics 3, 448–466 (2013).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials